Though the mechanistic proof of STIL function in details remains elusive, our study urges that STIL could be an important oncogene with an inherent ability to regulate multiple aspects of cancer progression in CRC, and it could be a warranted target for therapeutic intervention and prognostic marker in the future. The gene discussed is STIL; the disease is cancer.